Polyhydroxycarboxylates (MW 3800-14000) derived from phenolic (PDP) compounds were found to be selective inhibitors of human cytomegalovirus (CMV), herpes simplex Virus type 1 (HSV-1), type 2 (HSV-2), thymidine kinase-deficient (TK-c) HSV-1 and vaccinia virus replication at concentrations that are not toxic to the host cells. The PDP compounds were not inhibitory to parainfluenza virus, reovirus, Sindbis virus, or Semliki forest virus. The polycarboxylate aurintricarboxylic acid (ATA) (MW 1149-3336) also proved inhibitory to CMV and HSV replication. The anti-CMV and anti-HSV activities of the ATA polymers increased with increasing molecular weight. The mechanism of anti-CMV activity of both the PDP and ATA series of compounds can be attributed to the inhibition of virion attachment to the cells, probably due to an interaction of these polyanionic compounds with the positively charged domains of the viral envelope glycoproteins.
Introduction
Human cytomegalovirus (CMV) is one of the most important infectious pathogens in immunocompromised hosts, particularly allograft (kidney, liver, heart, lung, and bone marrow transplant) recipients and patients with the acquired immune deficiency syndrome (Tymset aI., 1989) . Furthermore, human cytomegalovirus infections can produce serious congenital defects in newborns (Stagno et aI., 1982; Britt et aI., 1991) . Ganciclovir [9-(1 ,3-dihydroxy-2-propoxymethyl)guanine, DHPGj and Foscavir [foscarnet, phosphonoformic acid (PFA)l are currently the only drugs for the treatment of severe CMV infections (Verheyden, 1988; Emanuel, 1990) . Our laboratory recently reported the potent and selective anti-CMV activity of the acyclic nucleoside phosphonate, HPMPC [(S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosinej (Snoeck et aI., 1988; Neyts et al., 1990 Neyts et al., , 1991a Neyts et al., ,b, 1992a . Ganciclovir, PFA,and HPMPC owe their anti-CMV activity to an inhibitory effect on viral DNA synthesis.
Several sulphated polymers, including dextran sulphate, heparin, pentosan polysulphate, fucoidan, carrageenans, sulphated cyclodextrins, polyvinylalcohol sulphate (PVAS), and co-polymers of acrylic acid with vinylalcoholsulphate (PAVAS), have proved to be highly potent and selective inhibitors of several enveloped viruses, including CMV and herpes simplex virus (HSV) , and human immunodeficiency virus (HIV) (Baba et al., 1988a (Baba et al., ,b,c, 1990 Ito et al., 1989; Schols et al., 1990a Schols et al., , 1991a . Their mode of action can be attributed to an inhibition of virus adsorption to the cell membrane, as shown, in particular, with HIV (Baba et sl., 1988c) and CMV (Neyts et al., 1992b) .
We now report on the anti-CMV and anti-HSV activity and the mechanism of anti-CMV activity of another class of anionic polymers, namely polyhydroxycarboxylates derived from phenolic (PDP) compounds and polymeric forms of the triphenylmethane derivative, aurlntrlcarboxylic acid (ATA). The PDP polyhydroxycarboxylates have been previously shown to inhibit the replication of HIV and other retroviruses (Sydow et al., 1986; Schols et al., 1991b) , influenza virus type A and B (Hills et al., 1986) , Coxsackie virus B4 (Eichhorn et al., 1984) and HSV (Kl6cking and Helbig, 1991) in vitro, and ATA polycarboxylates were shown to inhibit HIV replication in vitro (Balzarini et aI., 1986; Schols et al., 1989b; Cushman et al., 1991a,b) .
Results

Anti-CMVactivity of the PDP and ATA compounds
When the PDP compounds were evaluated for their inhibitory effect on the cytopathogenicity of CMV in HEL cells (Table 1) , KOP, GALOP, GENOP, HYKOP, PYROP, CHOP, and POP showed 50% antiviral effective concentrations (EC 5o ) ranging from 0.7 to 10 f.Lg rnl" , which is well below their 50% cytotoxic concentration (CC 50 ) . The compounds derived from dihydroxyphenylacetic acid (2,5-DHPOP and 3,4-DHPOP) also showed good anti-CMV activity. All compounds had to be present at the time of virus adsorption to exert their antiviral effect. The polymer derived from catechol (BOP) and the polymers obtained from the dihydroxytoluenes (2,3-DHTOP and 3,4-DHTOP) were virtually inactive against CMV.
Using radiolabelled virus we assessed the inhibitory effects of the PDP compounds on the bindi!",g of CMV with HEL cells. As shown in Table 1 , the EC so values of the compounds for inhibition of the binding of radiolabelled virions to the cells were comparable with the EC so values for inhibition of virus-induced cytopathogenicity. Compounds that proved not to be protective against CMVinduced cytopathogenicity (Le. BOP, 2,3-DHTOP, 3,4-DHTOP) had EC so values>70 ILg rnt " in the virus-cell In an additional set of experiments, varying-molecularweight fractions of the heterogeneous polymer aurintricarboxyJic acid (ATA), were evaluated for their anti-CMV activity ( Table 2 ). The ATA fraction with a MW > 3336 had an EC so value slightly higher than that of dextran sulphate, whereas the ATA fractions with a MW < 475 were virtually inactive against CMV. As noted for the PDP compounds, the EC so values of the ATA fractions for inhibition of EC so (I-'g ml- Cushman et al. (1991a) for MW determination. 
Activity of PDP compounds and ATA against other viruses
The PDP compounds were also examined for their inhibitory effect on the cytopathogenicity of viruses other than CMV (Table 3) , KOP, HYKOP, GENOP, GALOP, CHOP, POP, 2,5-DHPOP and 3,4-DHPOP showed an EC so of 7 to 20 ILgmr' against HSV-1, HSV-2, TK-HSV-1 and W; this is at a concentration well below the cytotoxic threshold. ThUS, the activity of the PDP compounds against HSV was weaker than against CMV. Also, the ATA fractions were active against HSV, albeit at a higher EC so than against CMV (Table 4 ). The PDP compounds were also evaluated, and found to be inactive, against the following viruses: polio virus type 1 (in HeLa cells), and Semliki forest virus, parainfluenza virus type 3, reovirus type 1, and Sindbis virus (in Vero cells) (data not shown). virus-induced cytopathogenicity were equivalent to the EC so values for inhibition of virus-cell binding and inhibition of lEA expression (Table 2) .
Discussion
Several polyhydroxycarboxylates derived from phenolic (PDP)compounds were found to be selective inhibitors of human cytomegalovirus (CMV) and herpes simplex virus (HSV) replication in vitro. Based on the ratio of CC so to EC so , the selectivity index of the compounds for inhibition of CMV infectivity ranged from <4 (2,3-DHTOP) to 175 (KOP). A close correlation was found between the inhibitory effects of the PDP compounds on CMV-induced AS COEFGHI 
Affinity of CMV particles for PDP and ATA compounds
Affinity chromatography with heparin-Sepharose columns was carried out to determine whether the PDP and ATA compounds were able to displace CMV particles that were bound to heparin. As shown in Fig. 1 (B) and Fig. 2 (B) , radiolabelled virus particles could be specifically bound to heparin-Sepharose columns (as revealed to the virtual absence of radioactivity in the eluate of these columns). Inclusion of dextran sulphate (MW 10000) (251Lg mr") in the elution buffer (Fig. 1C ) resulted in a displacement of all bound radiolabelled virions from the column. Also, KOP, GALOP, and HYKOP (at 25ILg rnl') ( Fig. 1D ,E,F) and the high molecular weight ATA fractions (at 100IL9 ml-1 ) (Fig.  2E,F ,G,H) were able to displace radiolabelled virions from the heparin-Sepharose column. Those compounds that had no anti-CMVactivity [Le.2,3-DHTOP, 3,4-DHTOP and BOP (Fig. 1G,H,I ), and the low molecular weight ATA fractions and aurin (Fig. 2C,D,I )] were not or were only weakly able to displace CMV from the heparin-Sepharose columns at the indicated concentrations. At a concentration of 50 ILg ml" KOP displaced 85% and BOP 28% of the bound virus, and at a concentration of 100 ILg mr' KOP displaced 84% and BOP 43% of the virus. cytopathogenicity, their inhibitory effects on expression of CMV specific immediate early antigens (lEA), and their inhibitory effects on CMV adsorption to the cells. Thus, the mechanism of antiviral action of the PDP compounds can be ascribed to inhibition of virus adsorption. A similar mechanism of action has also been found for the anti-CMV activity of sulphated polymers (Neyts et al., 1992b) . The antiviral activity of the PDP compounds clearly depends on the presence of a sufficient number of carboxylic groups. Compounds such as BOP, 2,3-DHTOP and 3,4-DHTOP which lack anti-CMV activity possess too few carboxylic acid groups per mol (7, 3, and 5, respectively), while for the active compounds this value is 8 or greater: A similar requirement for a sufficient number of carboxylic acid groups has recently been found for the anti-HIV activity of the PDP compounds (Schols et al., 1991b) . Another polyanionic compound, aurintricarboxylic acid (ATA), with potent anti-HIV activity (Balzarini et aI., 1986; Schols et el., 1989b; Cushman et al., 1991a,b ) also proved active against CMV. Low molecular-weight ATA fractions (MW < 475) showed no anti-CMV activity, while the high-molecular-weight fraction (MW > 3336) was almost as potent as dextran sulphate. A similar trend has been found for the inhibition of HIV replication by ATA fractions of different molecular weights (Cushman et al., 1991a,b) .
The observation that the anti-CMV activity, but not the cytotoxicity, increased with increasing molecular weights of the ATA fractions points to the specific role of the carboxylic acid groups in the antiviral activity of the ATA fractions. In fact, the most cytotoxic was the ATA derivative aurin from which the carboxylic acid groups had been stripped off (fable 2). As for the PDP compounds, similar EC so values were found for the anti-CMV activity of the ATA fractions, their inhibitory effects on CMV-specific lEA expression and their inhibitory effects on CMV binding to the cells. Thus, akin to the PDP compounds, the ATA compounds may owe their antiviral activity to interference with CMV attachment to the cells.
Recently, we found that sulphated polymers [such as dextran sulphate, pentosan polysulphate, heparin, and co-polymers of acrylic acid with vinylalcoholsulphate (PAVAS)] exhibit their inhibitory effect on CMV infectivity probably by occupying the sites on the virion envelope that are involved in the attachment of the virions to the cell surface constituent heparin sulphate (Neyts et al., 1992b) . This would be similar to the mechanism by which heparin inhibits HSV adsorption to the host cells (WuDunn and Spear, 1989; Shieh et al., 1992) .
In this report we showed that the polyhydroxycarbox-: ylates KOP, GALOP, and HYKOP are able to displace CMV virions that were bound to heparin immobilized on a Sepharose column. This may mean that polyhydroxycarboxylates compete with heparin for binding to those sites of the virion envelope that are necessary for attachment of the virus particles to the cell surface. Compounds such as 2,3-DHTOP, 3,4-DHTOP, and BOP that have too few carboxylic groups (andthus lack anti-CMV activity) proved unable to displace CMV virions that were bound to the heparln-Sepharose resin. Thus, the ability of the PDP compounds to displace CMV from the heparin-Sepharose seems to depend on their negative charge density and is related to whether they possess anti-CMV activity or not. The importance of a sufficient number of carboxylic groups is also evident from the molecular weight dependence of the anti-CMV activity of the polycarboxylates ATA. Low molecular-weight ATA (MW < 475) that had no anti-CMV activity, was unable to displace CMV virions from the heparin-Sepharose resin, while high-molecularweight ATA fractions (MW > 2326) did so very efficiently.
Apparently, the active PDP compounds exceeded the threshold molecular weight for anti-CMV activity and, similarly, the active ATA fractions exceeded the threshold density of negative charges. Schols et al. (1991 b) have found a close correlation between the anti-HIV activity of the PDP compounds and their inhibitory effects on anti-gp120 mAb binding. It has also been demonstrated that dextran sulphate and other sulphated polymers exhibit their anti-HIV activity by binding to the principal neutralizing domain (V3 loop) of gp120 (Schols et aI., 1990b; Callahan et aI., 1991) . This loop contains a high number of positively charged amino acids (Callahan et al., 1991) . Herold et al. (1991) showed that heparin can bind to glycoproteins gB and gC of HSV. Thus, one may assume that negatively charged compounds such as sulphated polymers and polycarboxylates with a sufficiently high number of carboxylic groups exhibit their inhibitory effect on viral infectivity through binding to positively charged domains of the glycoproteins of some enveloped viruses. These positively charged domains must be necessary for an efficient interaction of the virus particles with negatively charged receptor molecules (such as heparin sulphate proteoglycans) at the cell surface (Neyts et al., 1992b) .
In conclusion, poly(hydroxy)carboxylates with a sufficiently high molecular weight and number of carboxylic groups are effective in inhibiting CMV infectivity. They block the first step in the virus replicative cycle, i.e. virus adsorption to the cells, probably by interacting with positively charged domains of the viral envelope glycoproteins that are necessary for attachment of the virus particles to the cell surface. In this respect the poly(hydroxy)carboxylates behave similarly as the sulphated polymers.
Materials and Experimental procedures
Compounds
Aurintricarboxylic acid (ATA) polymers of different molecular weights were synthesized as described previously (Cushman et aI., 1991a) and aurin was from Aldrich Chemical Co. (Brussels, Belgium). Dextran sulphate [MW (dextran part): 5000 and 10000] was obtained from Pfeifer & Langen (Dormagen, Germany). The preparation and analytical data of the polyhydroxycarboxylates derived from the phenolic compounds were described elsewhere (Hanninen et a/., 1987) . The polyhydroxycarboxylates that were used in this study were the oxidation products of caffeic acid (KOP) [MW: 6000; 15 carboxylic groups equivalent per mol (e.p.m.)], hydrocaffeic acid (HYKOP) (MW: 6000, 28 carboxylic groups e.p.m.), gentisinic acid (GENOP) (MW: 5300; 8 carboxylic groups e.p.m.), gallic acid (GALOP) (MW: 7300; 18 carboxylic groups e.p.m.), pyrogallol (PYROP) (MW: 7300; 12 carboxylic groups e.p.m.), chlorogenic acid (CHOP)(MW: 14000; 30 carboxylic groups e.p.rn.), catechol (BOP) (MW: 5300; 7 carboxylic groups e.p.m.), protocatechuic acid (POP)(MW: 8000; 23 carboxylic groups e.p.m.), 2,5-dihydroxyphenylacetic acid (2,5-DHPOP) (MW: 6500, 12 carboxylic groups e.p.m.), 3,4-dihydroxyphenylacetic acid (3,4-DHPOP) (MW: 6000; 12 carboxylic groups e.p.m.), 2,5-dihydroxytoluene (2,5-DHTOP)(MW: 4700; 3 carbo-xylic groups e.p.m.), 3,4-dihydroxytoluene (3,4-DHTOP) (MW: 4300; 5 carboxylic groups e.p.m.) and 2,3-dihydroxytoluene (2,3-DHTOP) (MW: 3800; 4 carboxylic groups e.p.m.). The structure otthese compounds are presented in a recent report by Schols et a/. (1991b) .
Viruses
The virus strains used were as follows: herpes simplex virus type 1 (HSV-1)(strain KOS), HSV-2 (strain G),thymidine kinase-deficient (TK-) HSV-1 (B2006), vaccinia virus (VV), poliovirus type 1 and Sindbis virus, parainfluenza virus type 3 (ATCCVR-93), reovirus type 1 (ATCC VR-230), cytomegalovirus [strain Davis (ATCC VR-807) and strain AD-169 (ATCC VR-538)] and Semliki forest virus (ATCC VR-67) (De Clercq et et., 1980 Schols et el., 1990a) (ATCC: American Type Culture Collection, Rockville, MD, USA).
Antiviral assays
For all viruses (except for CMV) confluent cultures of human embryonic skin-muscle (E6SM), HeLa or Vero cells in microtitre trays were inoculated with virus at 100 times the CCID so (50% cell culture infective dose) per well in the presence of various concentrations of the test compounds. Virus-induced cytopathogenicity was recorded at 1-2 days post-infection for VSV,at 2 days for Coxsackie virus, Semliki forest virus and polio virus, at 2-3 days for HSV-1, HSV-2,TK-HSV-1,W, and Sindbis virus and at 5 days for reovirus. Forthe anti-CMVassays, human embryonic lung (HEL) fibroblasts in microtitre trays were infected with 100 PFU (plaque-forming units) of virus per well. Compounds were added at the same time as virus, and the cells were further incubated at 37"C. Virus-induced cytopathogenicity was recorded at 7 days as described previously (Snoeck et a/., 1988) .
Cytotoxicity assay HEL cells were seeded at a ratio of 3000 cells per well of 96-well microtitre plates in Eagle's minimal essential medium (MEM) containing 10% fetal calf serum (FCS). After 24 h, appropriate concentrations of the test compounds were added and the Cells were allowed to proliferate for 3 days. Then, the cells were detached by trypsinization and counted with a Coulter counter. The 50% cytotoxic concentration (CC so ) was estimated from graphic plots. Alternatively, the minimum cytotoxic concentration (MCG) of the compounds was recorded, that is the minimal concentration required to cause a microscopically detectable alteration of the morphology of confluent (stationary) cells.
Preparation of radiolabelled CMV
Confluent HEL cells were infected with about 2 PFU cell-1 of CMV .(strainDavis).After 5 days, 25 fLCi (45Ci mmOI-1 ) [methyPH]dThd was added in approximately 20 ml of medium. After a 2-3 day incubation period, the supernatant was harvested and cell debris was removed by two subsequent centrifugation steps in a Minifuge T at 2000 rpm for 10 min at 4°C. Virus was then pelleted by ultracentrifugation at 25 000 rpm in an Angle TI rotor (Beun de Ronde, Amsterdam, The Netherlands) for 2.5h at 4°C. The virus pellet was resuspended in an appropriate volume of MEM and the virus titre was determined by titration on HEL cells. Virus preparations had titres of about 10 8 PFU rnl:" and 10 6 cpm mr '.
Inoculation of HEL cells with radiolabelled CMV
Confluent HEL cells grown in 48-well micotitre plates were treated with 100 fLl of the test compounds for 1-5 min at room temperature. Then, 40 fLl of the radiolabelled virus suspension were added, and the cell cultures were further incubated for 60 min. Then the supernatants were removed and the cells were rinsed four times with 1ml phosphate-buffered saline (PBS). Cell lysis was performed with 200 fLl of a 1 N NaOH solution at room temperature. The lysed cell suspension was spotted on GF/C filters (Whatman Maidstone, UK) and radioactivity was determined in a toluene-based scintillant.
Analysis of CMV-induced immediate early antigens (lEA) in HEL cell cultures
Confluent HEL cell monolayers in 2-well tissue culture chamber slides (Nunc, Naperville, IL, USA) were treated with different concentrations of the appropriate compounds. Then, the cells were infected with CMV (strain Davis) at a MOl (multiplicity of infection) of approximately 0.2. A monoclonal antibody directed against an immediate early antigen (lEA)mAb E13 (Biosoft, Paris, France)was used to monitor CMV antigen expression at 24 h post infection. Analysis of the antigen expression was performed by a fluorescence microscopic assay as described before (Schols et a/., 1989a) . Quantitation of lEA expression by immunofluorescence microscopy was done by counting the lEA positive cells in 10 to 20 microscopic fields.
Affinity chromatography
One-nil heparin-Sepharose CL-6B or Sepharose 6B (Pharmacia, Uppsala, Sweden) columns were equilibrated with PBS and 200 ul ofasolution of the PDPcompounds at 25 fL9 mr" crof ATA at 100 fL9 mr ' in MEM was applied onto each column. Then, 15 fLl of the radioactive virus suspension were applied onto the columns, followed by 1.2ml MEM (control) or 1.2ml of the test compound solution. The eluent was collected and spotted onto GF/C filters (Whatman). The filters were washed 3 times with trichloroacetic acid (TCA) (10%) and then assayed for radioactivity.
